On the proteolytic inhibitory effect of human foetal and neoplastic tissues.
D004791:Enzyme Inhibitors / Q000032:analysis / Q000494:pharmacology*; D005260:Female; D005333:Fetus / Q000201:enzymology*; D005341:Fibrinolysin / Q000037:antagonists & inhibitors; D005342:Fibrinolysis; D006801:Humans; D009362:Neoplasm Metastasis; D010051:Ovarian Neoplasms / Q000201:enzymology*; D010447:Peptide Hydrolases / Q000032:analysis; D010534:Peritoneal Neoplasms / Q000201:enzymology; D011480:Protease Inhibitors; D014568:Urokinase-Type Plasminogen Activator / Q000037:antagonists & inhibitors
D004791:Enzyme Inhibitors; D011480:Protease Inhibitors; D010447:Peptide Hydrolases; D005341:Fibrinolysin; D014568:Urokinase-Type Plasminogen Activator